BOI:EPA
Boiron SA
€19.00
arrow_upward
+1.60%(+0.30) 1D
Nov 2, 5:35:01 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
€18.85
High
€19.50
Low
€18.70
Mkt. cap
328.10M
Avg. vol.
5.37K
Volume
0.00
P/E ratio
12.60
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.60M
No. of employees
3K
Open
€18.85
High
€19.50
Low
€18.70
Mkt. cap
328.10M
Avg. vol.
5.37K
Volume
0.00
P/E ratio
12.60
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.60M
No. of employees
3K
News stories
From web sources and news partners
Yahoo Finance
·
7 hours ago
AppLovin Is the Worst-Performing Stock in the S&P 500 This Year. Has the Market Overreacted?
Traders Union
·
5 hours ago
JOJO.Index outperformed long Treasuries with 6.26% return in August 2024, Michael A. Gayed notes
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA